32 results
ARS
2023 FY
CRBU
Caribou Biosciences Inc
25 Apr 24
Annual report to shareholders
4:06pm
; reputational harm; diminished profits; and the curtailment or restructuring of our operations. If any of the physicians or other providers or Table of Contents … , industrial espionage attacks, or insider threat attacks, which could result in financial, legal, business, or reputational harm. Our employees, clinical
ARS
93ismwk3f9954a iye
28 Apr 23
Annual report to shareholders
12:00am
DEF 14A
rck81
11 Aug 22
Definitive proxy
4:04pm
10-K
EX-10.39
xw8lyecnnld vmq
21 Mar 22
Annual report
4:19pm
10-K
EX-10.42
zp05 pz3r
21 Mar 22
Annual report
4:19pm
10-K
09g34
21 Mar 22
Annual report
4:19pm
8-K
EX-10.2
26ite90
28 Jul 21
Unregistered Sales of Equity Securities
4:05pm
8-K
EX-10.1
lgyxej40ndi80tb
28 Jul 21
Unregistered Sales of Equity Securities
4:05pm
8-K
EX-10.3
6gc4me
28 Jul 21
Unregistered Sales of Equity Securities
4:05pm
8-K
EX-10.4
qa5pgc
28 Jul 21
Unregistered Sales of Equity Securities
4:05pm
424B4
qk6h2
23 Jul 21
Prospectus supplement with pricing info
4:24pm
S-1/A
ino d7dct25
19 Jul 21
IPO registration (amended)
6:09am
S-1/A
EX-10.38
0qngaig 1v3ce2
19 Jul 21
IPO registration (amended)
6:09am
S-1/A
EX-10.40
qzzyv40c
19 Jul 21
IPO registration (amended)
6:09am
S-1/A
EX-10.34
udkoqb2uhwg0p8
19 Jul 21
IPO registration (amended)
6:09am